Skip to main content
SpringerLink
Log in

Male Androgenetic Alopecia

  • Chapter
  • First Online:
Andrology

  • 555 Accesses

Abstract

A first receding of the forehead-hairline border is eyed suspiciously by the majority of affected persons. Androgenetic alopecia is still interpreted as a sign of aging and those afflicted are often burdened by psychosocial stigmatization. Following anamnesis directed towards differentiated diagnosis, the treating physician must present therapeutic options with their respective pros and cons; these must be coordinated with the patient’s wishes and goals. New pathophysiological approaches and a better understanding of hair cycles, genetics, sex hormones, and signal cascades form the basis for possible therapeutic developments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adil A, Godwin M (2017) The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol 77:136–141

    PubMed  Google Scholar 

  • Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A (2019) The role of vitamins and minerals in hair loss: a review. Dermatol Ther (Heidelb) 9:51–70

    PubMed  Google Scholar 

  • Andy G, John M, Mirna S, Rachita D, Michael K, Maja K, Aseem S, Zeljana B (2019) Controversies in the treatment of androgenetic alopecia: the history of finasteride. Dermatol Ther 32:e12647

    PubMed  Google Scholar 

  • Barrón-Hernández YL, Tosti A (2017) Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia. Expert Opin Investig Drugs 26:515–522

    PubMed  Google Scholar 

  • Beach RA (2019) Case series of oral minoxidil for androgenetic and traction alopecia: tolerability & the five C’s of oral therapy. Dermatol Ther 31:e12707

    Google Scholar 

  • Blume-Peytavi U, Lönnfors S, Hillmann K, Garcia Bartels N (2012) A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. J Am Acad Dermatol 66:794–800

    CAS  PubMed  Google Scholar 

  • Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, Trakatelli M, Finner A, Kiesewetter F, Trüeb R, Rzany B, Blume-Peytavi U, European Dermatology Forum (2011) Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges 9(Suppl 6):S1–S57

    PubMed  Google Scholar 

  • Burg D, Yamamoto M, Namekata M, Haklani J, Koike K, Halasz M (2017) Promotion of anagen, increased hair density and reduction of hair fall in a clinical setting following identification of FGF5-inhibiting compounds via a novel 2-stage process. Clin Cosmet Investig Dermatol 10:71–85

    CAS  PubMed  PubMed Central  Google Scholar 

  • Choi BY (2020) Targeting Wnt/β-catenin pathway for developing therapies for hair loss. Int J Mol Sci 21:4915. https://doi.org/10.3390/ijms21144915

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Darwin E, Heyes A, Hirt PA, Wikramanayake TC, Jimenez JJ (2018) Low-level laser therapy for the treatment of androgenic alopecia: a review. Lasers Med Sci 33:425–434

    PubMed  Google Scholar 

  • Dey-Rao R, Sinha AA (2017) A genomic approach to susceptibility and pathogenesis leads to identifying potential novel therapeutic targets in androgenetic alopecia. Genomics 109:165–176

    CAS  PubMed  Google Scholar 

  • El-Ashmawy AA, El-Maadawy IH, El-Maghraby GM (2018) Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata. J Dermatolog Treat 29:55–64

    CAS  PubMed  Google Scholar 

  • Ellis JA, Scurrah KJ, Cobb JE, Zaloumis SG, Duncan AE, Harrap SB (2007) Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. Hum Genet 121:451–457

    PubMed  Google Scholar 

  • Fischer TW, Trüeb RM, Hänggi G, Innocenti M, Elsner P (2011) Melatonin in der topischen Behandlung der androgenetischen Alopezie. Akt Dermatol 37:410–418

    Google Scholar 

  • Foitzik K (2005) Neues aus der Haarforschung: Einfluss von Prolaktin, Retinoiden und Transforming Growth Factor-β auf das Haarwachstum. Akt Dermatol 31:109–116

    Google Scholar 

  • Foitzik K, Krause, K, Conrad F, Nakamura M, Funk W, Paus R (2006) Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol 168:748–775

    Google Scholar 

  • Gentile P, Garcovich S (2020) Systematic review of platelet-rich plasma use in androgenetic alopecia compared with Minoxidil®, Finasteride®, and adult stem cell-based therapy. Int J Mol Sci 21:2702

    CAS  PubMed  PubMed Central  Google Scholar 

  • Giordano S, Romeo M, di Summa P, Salval A, Lankinen P (2018) A meta-analysis on evidence of platelet-rich plasma for androgenetic alopecia. Int J Trichol 10:1–10

    Google Scholar 

  • Goren A, Naccarato T (2018) Minoxidil in the treatment of androgenetic alopecia. Dermatol Ther 31:e12686

    PubMed  Google Scholar 

  • Gubelin Harcha W, Barboza Martínez J, Tsai TF, Katsuoka K, Kawashima M, Tsuboi R, Barnes A, Ferron-Brady G, Chetty D (2014) A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol 70:489–498

    CAS  PubMed  Google Scholar 

  • Gupta AK, Charrette A (2014) The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride. J Dermatolog Treat 25:156–161

    CAS  PubMed  Google Scholar 

  • Gupta AK, Carviel J, MacLeod MA, Shear N (2017) Assessing finasteride-associated sexual dysfunction using the FAERS database. J Eur Acad Dermatol Venereol 31:1069–1075

    CAS  PubMed  Google Scholar 

  • Gupta S, Goyal I, Mahendra A (2019) Quality of life assessment in patients with androgenetic alopecia. Int J Trichol 11:147–152

    Google Scholar 

  • Hagenaars SP, Hill WD, Harris SE, Ritchie SJ, Davies G, Liewald DC, Gale CR, Porteous DJ, Deary IJ, Marioni RE (2017) Genetic prediction of male pattern baldness. PLoS Genet 13:e1006594

    PubMed  PubMed Central  Google Scholar 

  • Hamblin MR, Hasan T (2004) Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci 3:436–450

    CAS  PubMed  PubMed Central  Google Scholar 

  • Heilmann-Heimbach S, Hochfeld LM, Henne SK, Nöthen MM (2020) Hormonal regulation in male androgenetic alopecia-sex hormones and beyond: evidence from recent genetic studies. Exp Dermatol 29:814–827

    CAS  PubMed  Google Scholar 

  • Hoffmann R (2003) TrichoScan: a novel tool for the analysis of hair growth in vivo. J Investig Dermatol Symp Proc 8:109–115

    PubMed  Google Scholar 

  • Hosking AM, Juhasz M, Atanaskova Mesinkovska N (2019) Complementary and alternative treatments for alopecia: a comprehensive review. Skin Appendage Disord 5:72–89

    PubMed  Google Scholar 

  • Inui S, Itami S (2013) Androgen actions on the human hair follicle: perspectives. Exp Dermatol 22:168–171

    CAS  PubMed  Google Scholar 

  • Itin PH, Fistarol SK (2005) Hair shaft abnormalities—clues to diagnosis and treatment. Dermatology 211:63–71

    PubMed  Google Scholar 

  • Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, Schachner LA (2014) Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol 15:115–127

    PubMed  PubMed Central  Google Scholar 

  • Jo SJ, Shin H, Park YW, Paik SH, Park WS, Jeong YS, Shin HJ, Kwon O (2014) Topical valproic acid increases the hair count in male patients with androgenetic alopecia: a randomized, comparative, clinical feasibility study using phototrichogram analysis. J Dermatol 41:285–291

    CAS  PubMed  Google Scholar 

  • Jung JY, Yeon JH, Choi JW, Kwon SH, Kim BJ, Youn SW, Park KC, Huh CH (2014) Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride. Int J Dermatol 53:1351–1357

    CAS  PubMed  Google Scholar 

  • Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, Trakatelli M, Tosti A, Del Marmol V, Piraccini BM, Nast A, Blume-Peytavi U (2018) Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men—short version. J Eur Acad Dermatol Venereol 32:11–22

    CAS  PubMed  Google Scholar 

  • Kelly Y, Blanco A, Tosti A (2016) Androgenetic alopecia: an update of treatment options. Drugs 76:1349–1364

    CAS  PubMed  Google Scholar 

  • Kibar M, Aktan S, Bilgin M (2014) Scalp dermatoscopic findings in androgenetic alopecia and their relations with disease severity. Ann Dermatol 26:478–484

    PubMed  PubMed Central  Google Scholar 

  • Lee SW, Juhasz M, Mobasher P, Ekelem C, Mesinkovska NA (2018) A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women. J Drugs Dermatol 17:457–463

    PubMed  PubMed Central  Google Scholar 

  • Lee S, Lee YB, Choe SJ, Lee WS (2019) Adverse sexual effects of treatment with finasteride or dutasteride for male androgenetic alopecia: a systematic review and meta-analysis. Acta Derm Venereol 99:12–17

    CAS  PubMed  Google Scholar 

  • Lolli F, Pallotti F, Rossi A, Fortuna MC, Caro G, Lenzi A, Sansone A, Lombardo F (2017) Androgenetic alopecia: a review. Endocrine 57:9–17

    CAS  PubMed  Google Scholar 

  • Manabe M, Tsuboi R, Itami S, Osada SI, Amoh Y, Ito T, Inui S, Ueki R, Ohyama M, Kurata S, Kono T, Saito N, Sato A, Shimomura Y, Nakamura M, Narusawa H, Yamazaki M, Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male- and Female-Pattern Hair Loss (2018) guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. J Dermatol 45:1031–1043

    PubMed  Google Scholar 

  • Mubki T, Rudnicka L, Olszewska M, Shapiro J (2014) Evaluation and diagnosis of the hair loss patient: part I. history and clinical examination. J Am Acad Dermatol 71:415.e1–415.e15

    PubMed  Google Scholar 

  • Mysore V, Shashikumar BM (2016) Guidelines on the use of finasteride in androgenetic alopecia. Indian J Dermatol Venereol Leprol 82:128–134

    PubMed  Google Scholar 

  • Nieschlag E, Zitzmann M, Kamischke A (2003) Use of progestins in male contraception. Steroids 68:965–972

    CAS  PubMed  Google Scholar 

  • Norwood OT (1975) Male pattern baldness: classification and incidence. South Med J 68:1359–1365

    CAS  PubMed  Google Scholar 

  • Paladini RD, Saleh J, Qian C, Xu GX, Rubin LL (2005) Modulation of hair growth with small molecule agonists of the hedgehog signaling pathway. J Invest Dermatol 125:638–646

    CAS  PubMed  Google Scholar 

  • Phillips TG, Slomiany WP, Allison R (2017) Hair loss: common causes and treatment. Am Fam Physician 96:371–378

    PubMed  Google Scholar 

  • Prie BE, Iosif L, Tivig I, Stoian I, Giurcaneanu C (2016) Oxidative stress in androgenetic alopecia. J Med Life 9:79–83

    CAS  PubMed  PubMed Central  Google Scholar 

  • Raveh E, Cohen S, Levanon D, Negreanu V, Groner Y, Gat U (2006) Dynamic expression of Runx1 in skin affects hair structure. Mech Dev 123:842–850

    CAS  PubMed  Google Scholar 

  • Reguero-Del Cura L, Durán-Vian C, de Quintana-Sancho A (2020) RF-mesotherapy with Dutasteride: a future alternative treatment for androgenetic alopecia. Actas Dermosifiliogr 111:419–420

    CAS  PubMed  Google Scholar 

  • Rinaldi S, Bussa M, Mascaro A (2016) Update on the treatment of androgenetic alopecia. Eur Rev Med Pharmacol Sci 20:54–58

    CAS  PubMed  Google Scholar 

  • Sadick NS (2018) New-generation therapies for the treatment of hair loss in men. Dermatol Clin 36:63–67

    CAS  PubMed  Google Scholar 

  • Shin JW, Chung EH, Kim MB, Kim TO, Kim WI, Huh CH (2019) Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system. J Dermatol 46:139–143

    CAS  PubMed  Google Scholar 

  • Sinclair R, Greenland KJ, Sv E, Hoedemaker C, Chapman A, Zajac JD (2007) Men with Kennedy disease have a reduced risk of androgenetic alopecia. Br J Dermatol 157:290–294

    CAS  PubMed  Google Scholar 

  • Slominski AT, Semak I, Fischer TW, Kim TK, Kleszczyński K, Hardeland R, Reiter RJ (2017) Metabolism of melatonin in the skin: why is it important? Exp Dermatol 26:563–568

    CAS  PubMed  PubMed Central  Google Scholar 

  • Stefanato CM (2010) Histopathology of alopecia: a clinicopathological approach to diagnosis. Histopathology 56:24–38

    PubMed  Google Scholar 

  • Suchonwanit P, Thammarucha S, Leerunyakul K (2019) Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther 13:2777–2786

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sun X, Are A, Annusver K, Sivan U, Jacob T, Dalessandri T, Joost S, Füllgrabe A, Gerling M, Kasper M (2020) Coordinated hedgehog signaling induces new hair follicles in adult skin. Elife 9:e46756

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ummiti A, Priya PS, Chandravathi PL, Kumar CS (2019) Correlation of trichoscopic findings in androgenetic alopecia and the disease severity. Int J Trichol 11:118–122

    Google Scholar 

  • Vomund S, Schäfer A, Parnham MJ, Brüne B, von Knethen A (2017) Nrf2, the master regulator of anti-oxidative responses. Int J Mol Sci 18:2772

    PubMed  PubMed Central  Google Scholar 

  • Wolff H, Fischer TW, Blume-Peytavi U (2016) The diagnosis and treatment of hair and scalp diseases. Dtsch Arztebl Int 113:377–386

    PubMed  PubMed Central  Google Scholar 

  • Xu XG, Chen HD (2018) Prostanoids and hair follicles: implications for therapy of hair disorders. Acta Derm Venereol 98:318–323

    CAS  PubMed  Google Scholar 

  • Yoshitake T, Takeda A, Ohki K, Inoue Y, Yamawaki T, Otsuka S, Akimoto M, Nemoto M, Shimakura Y, Sato A (2015) Five-year efficacy of finasteride in 801 Japanese men with androgenetic alopecia. J Dermatol 42:735–738

    CAS  PubMed  Google Scholar 

  • Zhou Z, Song S, Gao Z, Wu J, Ma J, Cui Y (2019) The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clin Interv Aging 14:399–406

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhou Y, Yu S, Zhao J, Feng X, Zhang M, Zhao Z (2020) Effectiveness and safety of botulinum toxin type a in the treatment of androgenetic alopecia. Biomed Res Int 2020:1501893

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Klinikum Dortmund, Dortmund, Germany

    Dorothée Nashan

  2. Center of Reproductive Medicine and Andrology, University Hospital Münster, Münster, Germany

    Eberhard Nieschlag

Authors
  1. Dorothée Nashan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eberhard Nieschlag
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eberhard Nieschlag .

Editor information

Editors and Affiliations

  1. Center for Reproductive Medicine and Andrology, University Hospital Münster, Münster, Germany

    Eberhard Nieschlag

  2. Center for Reproductive Medicine and Andrology, University Hospital Halle (Saale), Martin Luther University Halle-Wittenberg, Halle (Saale), Germany

    Hermann M. Behre

  3. Center for Reproductive Medicine and Andrology, University Hospital Münster, Münster, Germany

    Sabine Kliesch

  4. Center for Reproductive Medicine and Andrology, University Hospital Münster, Münster, Germany

    Susan Nieschlag

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nashan, D., Nieschlag, E. (2023). Male Androgenetic Alopecia. In: Nieschlag, E., Behre, H.M., Kliesch, S., Nieschlag, S. (eds) Andrology. Springer, Cham. https://doi.org/10.1007/978-3-031-31574-9_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-31574-9_33

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-31573-2

  • Online ISBN: 978-3-031-31574-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation